Urologisk cancerforskning, Malmö
Anders Bjartell är forskargruppsledare för den här forskargruppenTranslational research on prostate cancer: Identification of molecular targets for development of new therapies in chemo- and hormone resistant prostate cancer. This includes: 1) In vitro studies and animal models. 2) Development and validation of biomarkers in tissue, blood and urine including circulating tumor cells. 3) Biobanking. 4) Clinical studies on imaging biomarkers for prognosis, predict
